Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (51-60 of 170) with videos related to

Pageof 17
Sort By:
Cancer Biology & Therapy|March 28, 2007
Gene-specific selection against experimental fanconi anemia gene inactivation in human cancerEike Gallmeier, Tomas Hucl, Eric S Calhoun, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survivalKaren N Wu, Maria Queenan, Jonathan R Brody, et al.
Human Pathology|June 25, 2010
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinomaAdam D Toll, Abhijit Dasgupta, Magdalena Potoczek, et al.
British Journal of Cancer|March 15, 2017
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancerMichael J Pishvaian, Andrew V Biankin, Peter Bailey, et al.
Cancer Biology & Therapy|September 5, 2008
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cellsChristine Hostetter, Lauren A Licata, Agnieszka Witkiewicz, et al.
Journal of Gastroenterology and Hepatology|November 26, 2009
Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathwayShayna L Showalter, Ziqiu Wang, Christina L Costantino, et al.
Journal of Pancreatic Cancer|January 12, 2019
Precious Data: Interim Report from the Jefferson Pancreas Tumor RegistryTheresa P Yeo, Harish Lavu, Avinoam Nevler, et al.
Molecular Cancer Research : MCR|December 1, 2020
Combined Targeting of PARG and Wee1 Causes Decreased Cell Survival and DNA Damage in an S-Phase-Dependent MannerLebaron C Agostini, Aditi Jain, Alison Shupp, et al.
Journal of the American College of Surgeons|May 30, 2009
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active targetAgnieszka K Witkiewicz, Christina L Costantino, Richard Metz, et al.
Molecular Cancer Research : MCR|September 30, 2018
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated CancerMahsa Zarei, Shruti Lal, Ali Vaziri-Gohar, et al.
Pageof 17

Showing results (51-60 of 170) with videos related to

Sort By:
Pageof 17
Cancer Biology & Therapy|March 28, 2007
Gene-specific selection against experimental fanconi anemia gene inactivation in human cancerEike Gallmeier, Tomas Hucl, Eric S Calhoun, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survivalKaren N Wu, Maria Queenan, Jonathan R Brody, et al.
Human Pathology|June 25, 2010
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinomaAdam D Toll, Abhijit Dasgupta, Magdalena Potoczek, et al.
British Journal of Cancer|March 15, 2017
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancerMichael J Pishvaian, Andrew V Biankin, Peter Bailey, et al.
Cancer Biology & Therapy|September 5, 2008
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cellsChristine Hostetter, Lauren A Licata, Agnieszka Witkiewicz, et al.
Journal of Gastroenterology and Hepatology|November 26, 2009
Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathwayShayna L Showalter, Ziqiu Wang, Christina L Costantino, et al.
Journal of Pancreatic Cancer|January 12, 2019
Precious Data: Interim Report from the Jefferson Pancreas Tumor RegistryTheresa P Yeo, Harish Lavu, Avinoam Nevler, et al.
Molecular Cancer Research : MCR|December 1, 2020
Combined Targeting of PARG and Wee1 Causes Decreased Cell Survival and DNA Damage in an S-Phase-Dependent MannerLebaron C Agostini, Aditi Jain, Alison Shupp, et al.
Journal of the American College of Surgeons|May 30, 2009
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active targetAgnieszka K Witkiewicz, Christina L Costantino, Richard Metz, et al.
Molecular Cancer Research : MCR|September 30, 2018
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated CancerMahsa Zarei, Shruti Lal, Ali Vaziri-Gohar, et al.
Pageof 17